Guest guest Posted September 19, 2010 Report Share Posted September 19, 2010 " Cancer care costs are a financial burden to patients, their families, and society as a whole. In 2006 medical expenses from cancer care in the United States were an estimated $104.1 billion. As the population ages, costs are expected to continue to increase as cancer prevalence rises. In addition, the development of expensive, targeted treatment strategies that are becoming the standard of care will most likely increase cancer costs. According to the World Health Organization (WHO) between 2004 and 2030, global cancer deaths will increase from 7.4 million to 11.8 million and cancer will be the leading cause of death this year followed by heart disease and stroke. " Remainder of story: http://www.caring4cancer.com/go/cancer/news?NewsItemId=45091 ____________________________ More on medical marijuana and its ingredients. This is the ingredient I think Tracey was describing. The active ingredient in marijuana is delta-9-tetrahydrocannabinol (THC). http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/D/Drugs.html#marijuana ___________________________ (cancer) " … a cannabinoid-based therapeutic strategy for neural diseases devoid of undesired psychotropic side effects could find in CBD [cannabidiol] a valuable compound in cancer therapies along with the perspective of evaluating a synergistic effect with other cannabinoid molecules and/or with other chemotherapeutic agents as well as with radiotherapy. " Journal of Pharmacology and Experimental Therapeutics, 2004. http://jpet.aspetjournals.org/content/308/3/838.full.pdf http://proxychi.baremetal.com/www.drugsense.org/cms/files/Cannabis%20Clinical%20\ Research.pdf __________________________ Marijuana and its derivatives have been used in medicine for many centuries, and currently there is a renewed interest in the study of the therapeutic effects of cannabinoids. Cannabinoids produce their effects by binding to specific plasma membrane G protein-coupled receptors. To date, two cannabinoid receptors have been characterized: the CB1 receptor, expressed primarily in the brain and in some peripheral tissues, and CB2 receptors, expressed by cells of the immune system. http://jpet.aspetjournals.org/content/308/3/838.full.pdf _____________________ FYI, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.